Remove 2016 Remove Data Remove Patients Remove Topical
article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

article thumbnail

CDC Still Soliciting Comments Regarding Chronic Pain Management Solutions

NORML

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

article thumbnail

THC Provides More Symptom Relief Than CBD, According To New Study

MassRoots

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111
article thumbnail

Pennsylvania’s Medical Cannabis Legislation Was Recently Amended

Veriheal

Under the terms of the legislation, House Bill 1024 will extend cannabis curbside services and indefinitely eradicate the patient cap for actively serving caregivers. In addition to this, patients will be given the opportunity to acquire a 90-day supply of cannabis. Previously, registered patients were limited to a 30-day supply.

article thumbnail

Study: Marijuana Decreases Migraine Pain

CannaMD

Showing more promise is medical marijuana, which has been found in studies to cut both headache severity and migraine severity nearly in half, which is excellent news for the millions of American men and women – and almost the 1 billion patients worldwide – who suffer from migraine pain. Marijuana & Migraines: New Research Study.

Marijuana 116
article thumbnail

New York’s Medical Marijuana Program: The Patient-Doctor Disconnect

MedicalJane

The state recently announced an expansion to its program that is beginning to open the door to improved patient access. Chronic pain, on its own, is already responsible for more than 7,500 new patients joining New York’s MMJ program. The struggle to connect with patients brought scrutiny from public officials, including state Sen.